The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Recurrence rates in cervical cancer patients treated with abdominal versus minimally invasive radical hysterectomy: A multi-institutional analysis of 700 cases.
 
Shitanshu Uppal
No Relationships to Disclose
 
Paola Gehrig
No Relationships to Disclose
 
Monica Hagan Vetter
No Relationships to Disclose
 
Brittany Anne Davidson
Honoraria - EMD Serono
 
Brittany F Lees
No Relationships to Disclose
 
Laurie Leigh Brunette
No Relationships to Disclose
 
Katherine Tucker
No Relationships to Disclose
 
KOJI MATSUO
No Relationships to Disclose
 
Kristin Leigh Bixel
No Relationships to Disclose
 
Allison Stuart Staley
No Relationships to Disclose
 
Walter H. Gotlieb
No Relationships to Disclose
 
Robert W. Holloway
Consulting or Advisory Role - Clovis Oncology
Speakers' Bureau - AstraZeneca; Bard/Davol; Clovis Oncology; Intuitive Surgical; Tesaro
 
Kathleen N. Moore
Consulting or Advisory Role - Advaxis; Aravive; AstraZeneca; Clovis Oncology; Genentech/Roche; Immunogen; Janssen Oncology; Merck; OncoMed; Pfizer/EMD Serono; Samumed; TESARO; VBL Therapeutics
Speakers' Bureau - AstraZeneca
Research Funding - Abbvie/Stemcentrx (Inst); Advaxis (Inst); Agenus (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Forty Seven (Inst); Genentech (Inst); Immunogen (Inst); Lilly (Inst); Lilly Foundation (Inst); Merck (Inst); Novartis Pharmaceuticals UK Ltd. (Inst); Novogen (Inst); PTC Therapeutics (Inst); Regeneron (Inst); Stem CentRx (Inst); Takeda (Inst); Tesaro (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - Genentech/Roche
Other Relationship - AstraZeneca
 
Stephen L. Rose
No Relationships to Disclose